CD Bioparticles Announces Advanced Engineering Platform for OMV-Based Bacterial Vaccine Development

CD Bioparticles launches comprehensive OMV-Based Bacterial Vaccines Development services for infectious disease and ...
Dermatology Advisor

FDA Declines to Review Moderna’s mRNA Flu Vaccine Application

The FDA issued a refuse-to-file letter for Moderna’s mRNA-based flu vaccine amid a shift toward stricter scrutiny of mRNA ...
Fierce Pharma

With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment

Mani Foroohar, M.D., of Leerink Partners, says that the decision reflects “how sharp the departure has been between the prior ...

What the FDA's rejection of Moderna's flu shot means for the future of vaccines

The Food and Drug Administration rejected Moderna's new flu shot. This raises questions about what it means for the future of vaccine development.

How vaccines give our immune systems a home advantage

We are now approaching six years since COVID-19 was declared a pandemic by the World Health Organization, yet talk of vaccines and our immune systems persists in our cultural conversations — from ...
National Academies of Sciences%2c Engineering%2c and Medicine

The Search for a COVID-19 Vaccine — ‘There’s No One Winner’

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...